Psomagen (XKRX:950200) Accounts Payable & Accrued Expense : ₩2,186 Mil (As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Psomagen Accounts Payable & Accrued Expense?

Psomagen's quarterly accounts payable & accrued expense increased from Sep. 2023 (₩827 Mil) to Dec. 2023 (₩3,033 Mil) but then declined from Dec. 2023 (₩3,033 Mil) to Mar. 2024 (₩2,186 Mil).

Psomagen's annual accounts payable & accrued expense declined from Dec. 2021 (₩3,235 Mil) to Dec. 2022 (₩2,899 Mil) but then increased from Dec. 2022 (₩2,899 Mil) to Dec. 2023 (₩3,033 Mil).

Psomagen Accounts Payable & Accrued Expense Historical Data

The historical data trend for Psomagen's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Psomagen Accounts Payable & Accrued Expense Chart

Psomagen Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

4,949.39

2,360.62

3,235.14

2,898.76

3,033.29

Psomagen Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial														1,637.04	639.23	827.25	3,033.29	2,185.83

Psomagen Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Psomagen (XKRX:950200) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Psomagen Inc (XKRX:950200) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1330 Piccard Drive, Suite 103, Rockville, MD, USA, 20850

Website

https://www.psomagen.com

Psomagen Inc, formerly Macrogen Corp provides total genomic solutions for both clinical and research purposes. It is mainly focused on end-to-end sequencing services. The company also offers services such as personal DNA tests, clinical sequencing, research sequencing, and others.

Psomagen (XKRX:950200) Headlines

No Headlines